2003 related articles for article (PubMed ID: 24848508)
21. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
Nestor MS; Ablon G; Gade A; Han H; Fischer DL
J Cosmet Dermatol; 2021 Dec; 20(12):3759-3781. PubMed ID: 34741573
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK; Talukder M; Shemer A
Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
[TBL] [Abstract][Full Text] [Related]
23. What's New in Therapy for Male Androgenetic Alopecia?
Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
25. Androgenetic alopecia: an update.
Kaliyadan F; Nambiar A; Vijayaraghavan S
Indian J Dermatol Venereol Leprol; 2013; 79(5):613-25. PubMed ID: 23974579
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: A blinded randomized clinical trial.
Sadeghzadeh Bazargan A; Tavana Z; Dehghani A; Jafarzadeh A; Tabavar A; Alavi Rad E; Goodarzi A
J Cosmet Dermatol; 2024 Feb; 23(2):543-551. PubMed ID: 37650533
[TBL] [Abstract][Full Text] [Related]
27. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
28. Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
Khandpur S; Suman M; Reddy BS
J Dermatol; 2002 Aug; 29(8):489-98. PubMed ID: 12227482
[TBL] [Abstract][Full Text] [Related]
29. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA; Miot HA; Kasprzak M; Müller Ramos P
JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
[TBL] [Abstract][Full Text] [Related]
30. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
Gentile P; Garcovich S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
[TBL] [Abstract][Full Text] [Related]
31. Pediatric androgenetic alopecia: A review.
Griggs J; Burroway B; Tosti A
J Am Acad Dermatol; 2021 Nov; 85(5):1267-1273. PubMed ID: 31415838
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
33. Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M; Tsuboi R; Itami S; Osada SI; Amoh Y; Ito T; Inui S; Ueki R; Ohyama M; Kurata S; Kono T; Saito N; Sato A; Shimomura Y; Nakamura M; Narusawa H; Yamazaki M;
J Dermatol; 2018 Sep; 45(9):1031-1043. PubMed ID: 29863806
[TBL] [Abstract][Full Text] [Related]
34. The potential role of minoxidil in the hair transplantation setting.
Avram MR; Cole JP; Gandelman M; Haber R; Knudsen R; Leavitt MT; Leonard RT; Puig CJ; Rose PT; Vogel JE; Ziering CL;
Dermatol Surg; 2002 Oct; 28(10):894-900; discussion 900. PubMed ID: 12410672
[TBL] [Abstract][Full Text] [Related]
35. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
36. A systematic review of clinical trials using single or combination therapy of oral or topical finasteride for women in reproductive age and postmenopausal women with hormonal and nonhormonal androgenetic alopecia.
Nobari NN; Roohaninasab M; Sadeghzadeh-Bazargan A; Goodarzi A; Behrangi E; Nikkhah F; Ghassemi M
Adv Clin Exp Med; 2023 Jul; 32(7):813-823. PubMed ID: 36897103
[TBL] [Abstract][Full Text] [Related]
37. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
Gupta AK; Talukder M; Williams G
J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
[TBL] [Abstract][Full Text] [Related]
38. The Efficacy and Safety of Finasteride Combined with Topical Minoxidil for Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Chen L; Zhang J; Wang L; Wang H; Chen B
Aesthetic Plast Surg; 2020 Jun; 44(3):962-970. PubMed ID: 32166351
[TBL] [Abstract][Full Text] [Related]
39. Natural products for male androgenetic alopecia.
Gupta AK; Talukder M; Bamimore MA
Dermatol Ther; 2022 Apr; 35(4):e15323. PubMed ID: 35044013
[TBL] [Abstract][Full Text] [Related]
40. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
